Hi Ladies,
Just received information from Andrea York, University of Washington School of Medicine (Seattle) regarding the next phase of their her2 vaccine clinical trial. They are enrolling 20 people into this study, which will use the her2/neu vaccine in conjunction with herceptin to see if it will increase the immune response to the vaccine. All you ladies on maintenance herceptin who wanted to give the vaccine clinical trial a shot - here's your chance. The trial is known as "Phase I-II Study of Combination Immunotherapy for the Generation of HER-2/neu(HER2) Specific Cytotoxic T Cells (CTL) in vivo". Please contact Andrea York, 202.616.9538 or by email at
ay5@u.washington.edu for information.
Kitty